Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Genentech, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Rutgers, The State University of New Jersey
Cedars-Sinai Medical Center
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
Pfizer
Weill Medical College of Cornell University
Celgene
Osaka University
Stanford University
Amgen
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Roswell Park Cancer Institute
Santa Maria Biotherapeutics
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Fox Chase Cancer Center
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Valerio Therapeutics
Valerio Therapeutics
University of Chicago
Altor BioScience
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Duke University
European Organisation for Research and Treatment of Cancer - EORTC
Astellas Pharma Inc
Pharmacyclics LLC.